{"nct_id":"NCT05116189","title":"Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-07","start_date":"2021-12-13","start_date_type":"ACTUAL","primary_completion_date":"2025-03-05","primary_completion_date_type":"ACTUAL","completion_date":"2028-10-25","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["MRK"]}